Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902469 · ClinicalTrials.gov registry record · NA
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving
A NA study of Craving, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT04902469 is a NA study of Craving that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 250 participants, roughly in line with the 237-participant average among 7 other Craving trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04902469, a NA study of Craving, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study uses fMRI and behavioral measures in and outside the laboratory to investigate the neurobehavioral mechanisms underlying the impact of pleasant olfactory cues (OCs) on cigarette craving. The investigators plan to randomize 278 participants to a pleasant OC condition or an odor blank (neutral) condition and due to anticipated drop out expect to run 250 adult (half female) smokers, including both daily and nondaily smokers through the protocol. This study involves three visits. In the first visit, participants will complete a baseline breath carbon monoxide reading, a brief odor threshold test, and complete a series of self-report measures. In the next session, participants who are 8-hrs deprived of nicotine will undergo a 60-minute fMRI scan that will include structural, resting state, and task-based data collection. The fMRI task involves completing a series of tasks designed to index responses linked to key neural networks found to relate to addiction (e.g., reward processing, working memory). Participants will also be exposed to smoking cues to heighten craving and then depending on their condition (randomly assigned) will either receive a pleasant or neutral (odor blank) OC. In the third session, behavioral data will be collected to test the impact of either a pleasant or neutral OC on cigarette craving using self-reported urge and behavioral measures linked to craving. Finally, for pilot purposes designed to offer data for a subsequent clinical study (beyond this study), participants will additionally complete a 7-day ecological momentary assessment (EMA) protocol in which they will monitor cigarette craving and initial data will be collected outside the laboratory to evaluate the impact of OCs on naturally occurring craving. It is hypothesized that pleasant OCs will disrupt craving brain states and attenuate craving (as compared to neutral olfactory cues). Further, it is hypothesized that individual variation in neural responses to cognitive
Conditions Studied
Interventions
- BEHAVIORAL Pleasant Odor
- BEHAVIORAL Odor Blank
Study Locations (1)
Pennsylvania
- The University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04902469
The ClinicalTrials.gov registry entry for NCT04902469 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 237-participant average among 7 other Craving trials with a reported enrollment target. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Craving appearing as the primary indexed condition, and to 2 interventions - of which Pleasant Odor is the first listed.
NCT04902469 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04902469 about?
NCT04902469 is a clinical study titled "Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving". The proposed study uses fMRI and behavioral measures in and outside the laboratory to investigate the neurobehavioral mechanisms underlying the impact of pleasant olfactory cues (OCs) on cigarette craving. The investigators plan to randomize 278 participants to a pleasant OC condition or an odor bla...
What is the current status of trial NCT04902469?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-12-01. Estimated completion is 2026-06.
What conditions does trial NCT04902469 study?
This clinical trial studies the following conditions: Craving.
What interventions are being tested in trial NCT04902469?
The interventions under investigation include: Pleasant Odor (BEHAVIORAL), Odor Blank (BEHAVIORAL).
Who is sponsoring clinical trial NCT04902469?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04902469 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Craving
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
State-dependent Interoception, Value-based Decision-making, and Introspection
RECRUITING · NA
-
Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students
RECRUITING · NA
-
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
COMPLETED · NA
-
CARESS: An Investigation of Effects of CARESS
COMPLETED · NA
-
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
RECRUITING · Early Phase 1
-
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.